1. Home
  2. ACRV vs SEVN Comparison

ACRV vs SEVN Comparison

Compare ACRV & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • SEVN
  • Stock Information
  • Founded
  • ACRV 2018
  • SEVN 1986
  • Country
  • ACRV United States
  • SEVN United States
  • Employees
  • ACRV N/A
  • SEVN N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • SEVN Real Estate Investment Trusts
  • Sector
  • ACRV Health Care
  • SEVN Real Estate
  • Exchange
  • ACRV Nasdaq
  • SEVN Nasdaq
  • Market Cap
  • ACRV 247.8M
  • SEVN 209.5M
  • IPO Year
  • ACRV 2022
  • SEVN N/A
  • Fundamental
  • Price
  • ACRV $8.04
  • SEVN $13.11
  • Analyst Decision
  • ACRV Strong Buy
  • SEVN Strong Buy
  • Analyst Count
  • ACRV 5
  • SEVN 3
  • Target Price
  • ACRV $22.40
  • SEVN $14.50
  • AVG Volume (30 Days)
  • ACRV 44.7K
  • SEVN 100.9K
  • Earning Date
  • ACRV 11-13-2024
  • SEVN 10-28-2024
  • Dividend Yield
  • ACRV N/A
  • SEVN 10.73%
  • EPS Growth
  • ACRV N/A
  • SEVN N/A
  • EPS
  • ACRV N/A
  • SEVN 1.28
  • Revenue
  • ACRV N/A
  • SEVN $30,401,000.00
  • Revenue This Year
  • ACRV N/A
  • SEVN N/A
  • Revenue Next Year
  • ACRV N/A
  • SEVN N/A
  • P/E Ratio
  • ACRV N/A
  • SEVN $10.07
  • Revenue Growth
  • ACRV N/A
  • SEVN N/A
  • 52 Week Low
  • ACRV $3.19
  • SEVN $10.96
  • 52 Week High
  • ACRV $11.90
  • SEVN $14.66
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 48.60
  • SEVN 43.76
  • Support Level
  • ACRV $7.69
  • SEVN $12.66
  • Resistance Level
  • ACRV $8.54
  • SEVN $13.24
  • Average True Range (ATR)
  • ACRV 0.34
  • SEVN 0.49
  • MACD
  • ACRV -0.03
  • SEVN -0.00
  • Stochastic Oscillator
  • ACRV 23.59
  • SEVN 29.92

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About SEVN Seven Hills Realty Trust

Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.

Share on Social Networks: